RE:RE:RE:RE:RE:House Positions for SVABioTeck wrote: ViaCyte's PEC-Encap device ran into problems in 2016 and the trial was stopped. They have been working with W.L. Gore to try to improve the device and will be starting the trial fall 2019. This device doesn't require immuno suppression. Their PEC-Direct device requires immunosuppression and is comparable to Sernova's device. This hasn't run into fibrosis issues and clinical trials are happening in Canada, USA and started in Europe Jan of 2019. If results are good Sernova is toast.
Biohazard,
Your true colors are showing. You know every detail about Viacycte.... yet it is a private company that you cannot invest in. Here you hope they have good results so Sva is toast..... Sva pouch is not a one trick pony. It can be used for many indications Hemohilia, Thyroid, other potential stem cell and targeted drug delivery systems. JDRF is not too keen on Viacycte.... ask them,,,, they favour Sernova and trust me they are familar with all the trials ongoing to treat diabetes. So tell me this BioDick, when do you expect results from this trial? I bet you are sitting on your hands and just waiting for it. Why are you even here on this blog anatgonizing everybody?
Sernova just needs resluts from a few more patients to validate that the pouch works and this not just a one off. I wonder if Viacycte device will cause weight loss ...... more like weight gain due to the fibrosis and bloating ...lol